Your individual results may differ
Tirzepatide is FDAapproved for specific indications, including type 2 diabetes and, at certain doses and brand names, chronic weight management in adults with defined BMI criteria plus at least one weight-related condition, when combined with lifestyle change
However, while Semaglutide is an excellent option for weight loss, a newer medication has entered the scene that may provide even more powerful results: Tirzepatide
The STEP trials demonstrated that semaglutide-treated patients achieved mean weight loss of 15.3% to 17.4% over 68 weeks, compared to 2.4% with placebo
Semaglutide is a synthetic analog of the natural incretin hormone known as glucagon-like peptide-1 (GLP-1)
consultation with a healthcare provider is essential